Marcello Damiani
Directeur/Membre du Conseil chez Cellarity Inc.
Postes actifs de Marcello Damiani
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Cellarity Inc.
 Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2019 | - |
Historique de carrière de Marcello Damiani
Anciens postes connus de Marcello Damiani
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BENEVOLENTAI | Directeur/Membre du Conseil | 04/05/2023 | 02/05/2024 |
| Independent Dir/Board Member | 04/05/2023 | 02/05/2024 | |
| MODERNA, INC. | Corporate Officer/Principal | 01/09/2018 | 01/01/2022 |
| BIOMÉRIEUX | Directeur Technique/Scientifique/R&D | 01/01/2009 | 01/01/2015 |
Formation de Marcello Damiani
| Trium Global Emba | Masters Business Admin |
| Institut d'Administration Des Entreprises De Toulouse | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
| France | 3 |
| Royaume-Uni | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MODERNA, INC. | Health Technology |
| BIOMÉRIEUX | Health Technology |
| BENEVOLENTAI | Health Technology |
| Entreprise privées | 2 |
|---|---|
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
Cellarity Inc.
Cellarity Inc. BiotechnologyHealth Technology Cellarity Inc. engages in the operation of platform to design medicines targeting the full cellular and molecular complexity of disease. The company was founded by Avak Kahvejian, James J. Collins, Noubar Afeyan, and Nicholas Plugis in 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Marcello Damiani
- Expérience
